TCS, HDFCBANK, SBI Liquid Fund (G)
Glaxosmithkline Pharmaceuticals Ltd.
Glaxosmithkline Phar
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Mid-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
Financial Strength
Stable
Ratios Analysis
Balance Sheet
Results Analysis
Cash Flow
Profit Loss
Key Metrics
Market Capitalisation
₹ 47037.28 Cr.
Enterprise Value
₹ 45938 Cr.
Shares Outstanding
16.94 Cr.
Dividend Yield
1.15%
Face Value
₹ 10
Book Value
₹ 112.35
TTM EPS
50.29 Cr.
TTM-PE
55.21
Latest Equity
169.41
Latest Reserve
₹ 1734
Peers Comparison
| Stocks | CMP (₹) | Mark. Cap Size | P/E | P/B | EPS | ROE |
|---|---|---|---|---|---|---|
| Wockhardt | Loading... | Small-cap | 0 | 0.66 | -38.82 | -17.32 |
| Ajanta Pharma | Loading... | Mid-cap | 25.89 | 4.49 | 46.7 | 17.68 |
| Ipca Laboratories | Loading... | Mid-cap | 57.39 | 4.96 | 21.57 | 8.7 |
| Glenmark Pharma | Loading... | Mid-cap | 44.14 | 1.39 | 10.53 | 4.07 |
